K-numberK251637
Device nameDewin Reproductive Media (Dewin Gamete Buffer [with HSA and without HSA]; Dewin Follicle Flushing Solution, Dewin One Step medium [with HSA and without HSA])
ApplicantDonnevie Medical Technology (Shanghai) Co. , Ltd.
Product codeMQL
Device classClass II
Decision dateAug 27, 2025
DecisionSubstantially Equivalent
Regulation884.6180
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Dewin Reproductive Media is a family of three solutions used in assisted reproductive procedures: Gamete Buffer (for short-term handling of gametes and embryos outside the incubator, including washing and intracytoplasmic sperm injection), Follicle Flushing Solution (for ovarian follicle flushing and oocyte collection), and One Step Medium (for embryo culture from fertilization to blastocyst stage and embryo transfer). All variants contain gentamicin and are offered in glass bottles with volumes of 25–100 mL.

Technological characteristics

The subject device and predicate share the same primary ingredient categories (inorganic salts, energy sources, amino acids, antibiotic, HSA, antioxidant, buffer, EDTA, phenol red) and sterilization method (aseptic filtration). Differences include pH specifications (7.2–7.5 vs. 7.2–7.6), osmolality (260–295 vs. 260–290 mOsm/kg), shelf-life (7 months for Gamete Buffer, 12 months for Follicle Flushing, 4 months for One Step vs. 6 months for predicate), and Mouse Embryo Assay (MEA) performance metrics with varying exposure times and developmental timepoints.

Test standards cited

ISO 13408-1:2008 & A1:2013 and ISO 13408-2:2018 (aseptic filtration and filling validation); ISO 20857:2010/(R)2015 (dry heat sterilization); ISO 11137-1:2006 and ISO 11137-2:2013 (radiation sterilization); USP <791>, <785>, <85>, <71> (pH, osmolarity, endotoxin, sterility); 2021 FDA Guidance Mouse Embryo Assay; ASTM D4169-22 (transportation testing); ISO 10993-5:2009, ISO 10993-10:2021, ISO 10993-23:2021 (biocompatibility); 2023 FDA guidance on ISO 10993-1.

Substantial equivalence argument

The subject device is substantially equivalent because it shares the same intended use and primary technological characteristics with the predicate VitaVitro Reproductive Media, uses identical sterilization methodology, and meets the same endotoxin and sterility standards. While formulation, pH, osmolality, shelf-life, and MEA specifications differ, the applicant asserts these differences do not raise different questions of safety and effectiveness. Comprehensive performance testing including aseptic processing validation, shelf-life studies demonstrating product specifications, and biocompatibility testing support that the device is as safe and effective as the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →